VetPlus
VetPlus is a family-owned UK veterinary nutraceutical manufacturer founded in 1995, producing science-backed supplements for companion animals across joint, brain, gastrointestinal, internal organ and skin health categories. Products are sold exclusively through veterinary practices in over 50 countries via six subsidiaries and 50+ exclusive partners.
- Company typePrivate
- Founded1995
- HeadquartersLytham, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What VetPlus does
VetPlus Limited is a family-owned veterinary nutraceutical manufacturer founded in 1995 by David Haythornthwaite in Lytham, Lancashire, UK, and now operating as part of the Tangerine Group. The company develops and produces science-backed nutritional supplements for companion animals — primarily dogs and cats — and livestock (ovine), spanning six therapeutic categories: joint support, brain and behaviour, gastrointestinal, internal organs, skin and coat, and ovine colostrum. Its flagship product SYNOQUIN, launched in 1998, has sold over 1.5 million packs worldwide and is described as recommended by more vets in more countries than any other joint supplement. Recent product extensions include APRYLIC (the UK's first MCT supplement for brain health, 2023) and VETSALVE (a topical wound-management salve, 2023).
The company operates a GMP-certified manufacturing facility at Animal House, Boundary Road, Lytham, where over 90% of products are produced in-house and each SKU passes through at least 16 quality checks before release. Formulations use natural ingredients including glucosamine, chondroitin, omega-3 essential fatty acids, pre/pro/postbiotics, medium chain triglycerides, and multi-source fibre blends. The proprietary PLASID mobile app, launched in 2021, extends the company's footprint into behavioural and cognitive health content for vets and pet owners.
VetPlus distributes exclusively through veterinary practices in over 50 countries — a deliberate channel strategy that rejects retail and online pharmacy routes. Its international footprint is built on six wholly-owned subsidiaries (Ireland, Germany, Spain, Portugal, USA, Japan), two regional support offices (Singapore, Argentina), and more than 50 exclusive distribution partners across Europe, LATAM, Asia-Pacific, the Middle East and Africa. The company monetises through direct product supply to veterinary practices, supported by dedicated sales representatives, CPD-accredited education, practice business development plans, merchandising support, a technical helpline and the VetPlus Education Centre. Consumer pricing is not publicly disclosed and the company carries no enterprise customer concentration.
VetPlus firmographics
Firmographics- Name
- VetPlus
- Legal name
- VetPlus Limited
- Website
- https://vetplusglobal.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- VetPlus is a family-owned UK veterinary nutraceutical manufacturer founded in 1995, producing science-backed supplements for companion animals across joint, brain, gastrointestinal, internal organ and skin health categories. Products are sold exclusively through veterinary practices in over 50 countries via six subsidiaries and 50+ exclusive partners.
- Ownership category
- akta.pro rank
VetPlus industry classification
Industry- Product category
- Veterinary Nutraceuticals
- NAICS
- Animal Food Manufacturing (31111)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Species-Specific Supplements (Dog/Cat/Other Companion Species) (HLAMALAN)
- akta.pro secondary industries
- Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine) (HLAMALAO), Immune Support Supplements (HLAMALAE), Companion Animal Therapeutic Diets (Prescription Diets) (HLAMAHAA)
Keywords
Where VetPlus is headquartered
LocationHeadquarters
- HQ city
- Lytham
- HQ country
- United Kingdom
- HQ region
- Europe
Offices9 records
Markets served
VetPlus business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Veterinary Nutraceutical Products: Sale of veterinary nutraceutical supplements across five key health categories (joint support, brain & behaviour, gastrointestinal, internal organs, skin & coat) exclusively through veterinary practices. Products are sold as tablets, capsules, powders, liquids, sachets and topical formats. Revenue is generated through direct supply relationships with veterinary practices globally, supported by sales representatives.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | SUSTAIN FOR CATS — 30-sachet pack |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
VetPlus product offering
Product offeringCore offering
VetPlus manufactures and sells science-backed veterinary nutraceutical supplements for companion animals (dogs and cats) and livestock (lambs). Its product range covers five therapeutic areas — joint support, brain and behaviour, gastrointestinal, internal organs, and skin and coat — produced in-house at a GMP-certified facility in Lytham, Lancashire. Products are distributed exclusively through veterinary practices in over 50 countries.
Product overview
VetPlus is a family-owned veterinary nutraceutical company founded in 1995, offering a comprehensive range of scientifically formulated supplements for companion animals. The product portfolio spans five key therapeutic areas: Joint Support (SYNOQUIN®, SYNOQUIN® FOR CATS, SYNOQUIN® GROWTH, SYNOQUIN® LARGE BREED CAPSULES/TABLETS, SYNOQUIN® MEDIUM BREED CAPSULES), Brain & Behaviour (AKTIVAIT® FOR CATS, AKTIVAIT® MEDIUM/LARGE BREED, AKTIVAIT® SMALL BREED, APRYLIC®, CALMEX®, CALMEX® DIFFUSER, CALMEX® FOR CATS, CALMEX® ON THE MOVE), Internal Organs (CANINE CYSTAID®, CYSTAID®, FLUMAX®, GOMEGA®, GOMEGA® FOR CATS, KAMINOX®), Gastrointestinal (COBALIN®, COMPLIVIT®, FIBOR®, LYPEX®, PROMAX® LARGE/MEDIUM BREED, SUSTAIN® FOR CATS, SUSTAIN®), and Skin & Coat (COATEX®, COATEX® Pump, COATEX® M SHAMPOO, COATEX® S SHAMPOO, VETSALVE®), plus Ovine products (LAMAID®). Products are manufactured in their GMP-certified UK facility in Lytham, Lancashire, and sold exclusively through veterinary practices in over 50 countries worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- SYNOQUIN®: Leading joint support supplement for dogs and cats, supported by published clinical trial. Recommended by more vets in more countries than any other joint supplement.
- COATEX®
- AKTIVAIT®
- CALMEX®
- PROMAX®
- FIBOR®
- COBALIN®
- COMPLIVIT®
- LYPEX®
- CYSTAID®
- FLUMAX®
- GOMEGA®
- KAMINOX®
- SAMYLIN®
- APRYLIC®
- VETSALVE®
- LAMAID®
- SUSTAIN®
- SYNEQUIN®
- PLASID®
Products and services
- SYNOQUIN Leading veterinary joint supplement combining glucosamine, chondroitin, omega 3 essential fatty acids and antioxidants to support cartilage and overall joint health in dogs and cats. Recommended by more vets in more countries than any other joint supplement.
- AKTIVAIT Brain health supplement for senior dogs and cats, supporting cognitive function and addressing age-related behavioural changes. Available in small breed, medium/large breed, and cat formulations.
- APRYLIC Medium chain triglyceride (MCT) supplement to help support brain health in dogs and cats. UK's first MCT supplement for veterinary use.
- CALMEX Calming supplement range for dogs and cats to help maintain a normal disposition during challenging situations. Includes tablet format for dogs, liquid for cats, plug-in diffuser, and in-car calming product (CALMEX ON THE MOVE).
- CYSTAID Supplement for supporting urinary and bladder health in dogs and cats. Available in canine and feline formulations.
- FLUMAX Liver support supplement for pets, supporting normal hepatic function.
- GOMEGA Omega fatty acid supplement for heart health support in dogs and cats. Available in canine and feline formulations.
- KAMINOX Potassium supplement in sachet form for cats and dogs.
- COBALIN B vitamin supplement for pets supporting gastrointestinal and metabolic health.
- COMPLIVIT Multivitamin supplement for pets supporting overall digestive health.
- FIBOR Fibre supplement containing seven different natural sources of fibre to promote healthy digestion in pets. Contains 45% fibre content.
- LYPEX Digestive enzyme supplement supporting pancreatic and digestive function in pets.
- PROMAX Pioneering nutritional supplement supporting normal digestive function in dogs. Available in large breed and medium breed formulations.
- SUSTAIN Nutraceutical combining prebiotic, probiotic and postbiotic ingredients for gastrointestinal and immune health. SUSTAIN FOR CATS was the first UK veterinary product combining all three in one formulation. Available in dog and cat sachet formats.
- COATEX Veterinary-recommended range supporting normal skin function and healthy coat in dogs and cats. Contains omega 3 and 6 essential fatty acids and vitamins. Includes capsule, pump, and shampoo formulations (M and S for sensitive skin).
- VETSALVE Topical skin salve to help support wound management in pets.
- LAMAID Colostrum supplement for lambs to provide the first and most important feed when maternal colostrum may be insufficient, supporting flock health and reducing lamb mortality.
- PLASID App Mobile app offering vets and pet owners exclusive behavioural and cognitive health support and advice for pets.
Quantifiable outcome
- SYNOQUIN — over 1.5 million packs sold worldwide since 1998 launch
- +2 more outcomes
Companies that use VetPlus
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
VetPlus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
VetPlus partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and regional.
- VetPlus K.K. (Japan)coreJapanese wholly owned subsidiary.
- VetPlus Ltd Sucursal ArgentinacoreRegional support office in Buenos Aires opened in 2021 to support growing base of Latin America countries.
- Vetclusive Lda (Portugal)corePortuguese subsidiary established in Lisbon.
- Vetclusive Inc. (USA)coreAmerican subsidiary established in Atlanta, Georgia. Positioned as the 'Home of Nutraceuticals'.
- VetPlus Asia Pte Ltd (Singapore)coreRegional support office opened in Singapore to support ongoing expansion in Asia.
- VetPlus GmbH (Germany)coreGerman subsidiary in Düsseldorf supporting vets throughout Germany.
- VetPlus Ltd (Ireland)coreIrish subsidiary opened in Dublin, supporting vets throughout the Republic of Ireland.
- Laboratorios VetPlus, S.L. (Spain)coreFirst overseas subsidiary opened in Barcelona, Spain in 2003. Wholly owned subsidiary managing sales throughout Spain.
- PetHealth (Greece)regionalExclusive distribution partner in Greece. First international exclusive partner 'John. Mademochoritis & CO' established in 2004.
- VetPlus European Partner NetworkregionalExclusive distribution partners across Belgium (VetPlus BE), Bulgaria (Akva LTD), Czech Republic (VetPlus Trade s.r.o), Denmark (VetPlus Danmark), Finland (Finnpharma), Hungary (VetTrade KFT), Iceland (Fjölráð ehf), Italy (Vet Bros Company), Netherlands (VP Veterinary Products), Norway (VESO), Poland (Fenix Vet), Romania (SC Maravet), Slovakia (VetPlus Slovakia s.r.o), Switzerland (Arovet AG).
- VetPlus Latin American Partner NetworkregionalExclusive distribution partners across Argentina (Agroinsumos), Bolivia (ANM Ltda), Chile (Ludipek), Costa Rica (Innovett Animal Care S. A.), Ecuador (Farmavet S.A), Guatemala (Reinsa), Panama (Vetsolutions Inc), Peru (TotalVet SAC.), Paraguay (Brunelca).
- VetPlus Asia-Pacific Partner NetworkregionalExclusive distribution partners across Hong Kong (The Veterinary Nutraceutical Company), Indonesia (Mega Utama Medica), Malaysia (Ritma Prestasi Sdn Bhd), Philippines (Agfield International Corporation), Singapore (Ritma Premier), South Korea (Fovets), Taiwan (JS BioCare Co., Ltd.), Thailand (T.J. Animal Health).
- VetPlus Africa, Middle East & Australasia PartnersregionalPartners include Egypt (Vet4Ever), Ivory Coast (SN Proveci), New Zealand (VetExpress), India (Vetential), Saudi Arabia (Nova Pharma Trading), Turkey (Fi Pet Veteriner), UAE (Nova Pharma Trading).
Scale indicators8 records
Recent moves16 records
Expansion highlights7 records
VetPlus competitors and assessment
Company assessmentDirect peers
- Virbac: French animal health company offering pharmaceuticals, vaccines, and pet nutrition/supplements. Directly comparable in product breadth and vet-channel GTM across multiple geographies.
- Ceva Santé Animale: Global veterinary pharmaceutical company with companion animal products spanning dermatology, cardiology, behaviour and supportive care. Comparable channel strategy and product breadth to VetPlus.
- Lintbells (YuMOVE): UK-based pet supplement company best known for YuMOVE joint supplement. The closest UK-headquartered competitor to VetPlus, also science-positioned though with stronger direct-to-consumer/retail distribution.
- Vetoquinol: Global veterinary pharmaceuticals and nutraceuticals company with a strong presence in joint, dermatology, and supportive care categories. Closely comparable business model selling through vet practices worldwide.
- Nutramax Laboratories: US-based maker of Cosequin and Dasuquin joint supplements for pets. The most direct global competitor to VetPlus's SYNOQUIN franchise, also selling through the veterinary channel with a science-backed positioning.
Broad incumbents
- Zoetis: World's largest animal health company with a broad portfolio across species including companion animal diagnostics, dermatology, and supportive care. Represents the upper bound of incumbent scale.
- Elanco Animal Health: One of the largest global animal health companies with companion animal supplements and therapeutics. A broad incumbent whose portfolio overlaps with VetPlus's categories.
- Hill's Pet Nutrition: Owned by Colgate-Palmolive, Hill's sells prescription and therapeutic pet diets through veterinary channels globally. Broader and larger scale than VetPlus but overlapping in the vet-only therapeutic nutrition space.
- Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company focused on companion animal endocrinology, dermatology, and supportive therapies. Larger and broader portfolio than VetPlus but operates in adjacent categories.
Emerging players
- GWF Nutrition: UK-based equine and companion animal supplement manufacturer. Smaller scale than VetPlus but directly comparable as a specialist nutraceutical maker with vet/professional channel focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
VetPlus social profiles
Digital presenceVetPlus compliance and trust
Trust signalCompliance1 record
VetPlus financial estimates
Financial estimateRevenue estimate
Valuation estimate
VetPlus leadership team
Management profileNumber of profiles
Profiles1 record
VetPlus subsidiaries and ownership
Company hierarchySubsidiaries8 records
VetPlus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VetPlus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VetPlus
What does VetPlus do?
VetPlus manufactures and sells science-backed veterinary nutraceutical supplements for companion animals (dogs and cats) and livestock (lambs). Its product range covers five therapeutic areas — joint support, brain and behaviour, gastrointestinal, internal organs, and skin and coat — produced in-house at a GMP-certified facility in Lytham, Lancashire. Products are distributed exclusively through veterinary practices in over 50 countries.
Is VetPlus a public or private company?
VetPlus is a private company. It is classified as family owned and is currently operating.
When was VetPlus founded?
VetPlus was founded in 1995. It employs 101 to 250 people.
Where is VetPlus based?
VetPlus is headquartered in Lytham, United Kingdom, in the Europe region.
How does VetPlus make money?
One revenue line is on record: veterinary Nutraceutical Products.
Who are VetPlus's main competitors?
Direct peers on record are Virbac, Ceva Santé Animale, Lintbells (YuMOVE), Vetoquinol and Nutramax Laboratories. Broad incumbents are Zoetis, Elanco Animal Health, Hill's Pet Nutrition and Dechra Pharmaceuticals. GWF Nutrition is listed as an emerging player.
Does VetPlus have an API?
No public API is recorded for VetPlus.
What industry is VetPlus in?
VetPlus's product category is Veterinary Nutraceuticals. Its primary akta.pro industry code is HLAMALAN, Species-Specific Supplements (Dog/Cat/Other Companion Species), with a secondary code of HLAMALAO, Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine). Its NAICS code is 31111 and its SIC code is 2000.